|
|
||||||||
NEUROREGULATION AND MOTILITY
Departments of Internal Medicine, Physiology and Biophysics, Enteric Neuromuscular Disorders and Visceral Pain Center, Division of Gastroenterology, The University of Texas Medical Branch at Galveston, Galveston, Texas 77555-1064
Submitted 17 September 2003 ; accepted in final form 12 December 2003
Inflammation impairs the circular muscle contractile response to muscarinic (M) receptor activation. The aim of this study was to investigate whether the expression of muscarinic receptors, their binding affinity, and the expression and activation of receptor-coupled G proteins contribute to the suppression of contractility in inflammation. The studies were performed on freshly dissociated single smooth muscle cells from normal and inflamed canine ileum. Northern blotting indicated the presence of only M2 and M3 receptors on canine ileal circular muscle cells. Inflammation did not alter the mRNA or protein expression of M2 and M3 receptors. The maximal binding and Kd values also did not differ between normal and inflamed cells. However, the contractile response to ACh in M3 receptor-protected cells was suppressed, whereas that in M2 receptor-protected cells was enhanced. Further experiments indicated that the expression and binding activity of G
q/11 protein, which couples to M3 receptors, were downregulated, whereas those of G
i3, which couples to M2 receptors, were upregulated in inflamed cells. We concluded that inflammation depresses M3 receptor function, but it enhances M2 receptor function in ileum. These effects are mediated by the differentially altered expression and binding activity of their respective coupled G
q/11 and G
i3 proteins.
smooth muscle; motility; inflammatory bowel disease; signalopathy; acetylcholine
This article has been cited by other articles:
![]() |
S. K. Sarna Are interstitial cells of Cajal plurifunction cells in the gut? Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G372 - G390. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohama, M. Hori, E. Momotani, Y. Iwakura, F. Guo, H. Kishi, S. Kobayashi, and H. Ozaki Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-{alpha} and causes motility disorders Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1429 - G1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Sarna Molecular, functional, and pharmacological targets for the development of gut promotility drugs Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G545 - G555. [Abstract] [Full Text] [PDF] |
||||
![]() |
R W Wells and M G Blennerhassett Divergent changes to muscarinic and serotonergic signalling following colitis Gut, December 1, 2005; 54(12): 1699 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Gerthoffer Signal-Transduction Pathways that Regulate Visceral Smooth Muscle Function III. Coupling of muscarinic receptors to signaling kinases and effector proteins in gastrointestinal smooth muscles Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G849 - G853. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Akbarali Signal-Transduction Pathways that Regulate Smooth Muscle Function II. Receptor-ion channel coupling mechanisms in gastrointestinal smooth muscle Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G598 - G602. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |